This ain’t the time to bicker with our CEOAs I said investors through investor relations and voting will settle our internal matters and we can move on from this. This definitely isn't the time to call for our CEO to step down who is laser focused and on the midst of major deals and building a multi billon dollar revenue generating company which is Tilray by next year no doubt in my mind. Let's get past this bickering on these boards and focus on what Tilrays doing right which is everything. We will handle internal matters as I said many times through investor relations and maybe Board and Irwin along with the investors come to an understanding. Until then let's keep dominating. I forecast nearing 200 million revenue UsD next quarter with no lockdowns or any other major event slowing sales and orders down. Hopefully our distribution across the globe especially to CC Pharma continues to grow by decent margins and we have no excess inventory worth writing down. I believe we're on the right track. I liked this quarter financial report.